ADARx Pharmaceuticals
San Diego
About ADARx Pharmaceuticals
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $332.0M
- Last round: Series Unknown (Feb 2025)
- Website: adarx.com
- Phone: (877) 232-7974
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/adarx-pharmaceuticals-42132 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.